Israel Englander Biogen Inc. Transaction History

Millennium Management LLC

$199 Billion
Q3 2024

A detailed history of Israel Englander (Millennium Management LLC) transactions in Biogen Inc. stock. As of the latest transaction made, Millennium Management LLC holds 29,600 shares of BIIB stock, worth $4.62 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

29,600

Previous 239,847 87.66%

Holding current value

$4.62 Million

Previous $55.6 Million 89.68%

% of portfolio

0.0%

Previous 0.03%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$189.07 - $236.8 $29.9 Million - $37.5 Million	158,289 Added 66.0%	398,136 $77.2 Million
Q2 2024 Aug 14, 2024	BUY	$190.52 - $236.72 $12.1 Million - $15 Million	63,435 Added 35.96%	239,847 $55.6 Million
Q1 2024 May 15, 2024	BUY	$212.02 - $267.71 $36.4 Million - $46 Million	171,877 Added 3790.01%	176,412 $38 Million
Q4 2023 Feb 14, 2024	SELL	$222.59 - $267.94 $8.82 Million - $10.6 Million	-39,639 Reduced 89.73%	4,535 $1.17 Million
Q2 2023 Aug 14, 2023	SELL	$275.25 - $318.06 $129 Million - $149 Million	-469,218 Reduced 91.4%	44,174 $12.6 Million
Q1 2023 May 15, 2023	BUY	$256.56 - $292.34 $44.8 Million - $51.1 Million	174,807 Added 51.63%	513,392 $143 Million
Q4 2022 Feb 14, 2023	SELL	$252.44 - $306.72 $145 Million - $176 Million	-574,120 Reduced 62.9%	338,585 $93.8 Million
Q3 2022 Nov 14, 2022	BUY	$194.69 - $268.46 $64.5 Million - $88.9 Million	331,058 Added 56.92%	912,705 $244 Million
Q2 2022 Aug 15, 2022	SELL	$187.54 - $223.02 $4.23 Million - $5.03 Million	-22,566 Reduced 3.73%	581,647 $119 Million
Q1 2022 May 16, 2022	BUY	$193.77 - $244.14 $37.1 Million - $46.7 Million	191,325 Added 46.34%	604,213 $127 Million
Q4 2021 Feb 14, 2022	BUY	$223.92 - $287.77 $31.6 Million - $40.6 Million	141,069 Added 51.9%	412,888 $99.1 Million
Q3 2021 Nov 15, 2021	SELL	$282.99 - $369.05 $9.96 Million - $13 Million	-35,210 Reduced 11.47%	271,819 $76.9 Million
Q2 2021 Aug 16, 2021	BUY	$259.0 - $414.71 $39.4 Million - $63.1 Million	152,271 Added 98.39%	307,029 $106 Million
Q1 2021 May 17, 2021	SELL	$242.95 - $284.63 $23 Million - $26.9 Million	-94,658 Reduced 37.95%	154,758 $43.3 Million
Q4 2020 Feb 16, 2021	SELL	$236.26 - $355.63 $6.63 Million - $9.97 Million	-28,043 Reduced 10.11%	249,416 $61.1 Million
Q3 2020 Nov 16, 2020	BUY	$264.77 - $305.71 $47 Million - $54.2 Million	177,339 Added 177.13%	277,459 $78.7 Million
Q2 2020 Aug 14, 2020	BUY	$258.66 - $342.55 $7.19 Million - $9.52 Million	27,785 Added 38.41%	100,120 $26.8 Million
Q1 2020 May 14, 2020	SELL	$268.85 - $341.04 $120 Million - $153 Million	-447,279 Reduced 86.08%	72,335 $22.9 Million
Q4 2019 Feb 14, 2020	SELL	$220.06 - $304.07 $29.5 Million - $40.8 Million	-134,114 Reduced 20.52%	519,614 $154 Million
Q3 2019 Nov 14, 2019	BUY	$217.44 - $243.88 $38.7 Million - $43.4 Million	178,008 Added 37.42%	653,728 $152 Million
Q2 2019 Aug 15, 2019	SELL	$219.29 - $241.72 $17.2 Million - $19 Million	-78,399 Reduced 14.15%	475,720 $111 Million
Q2 2019 Aug 14, 2019	BUY	$219.29 - $241.72 $97.9 Million - $108 Million	446,361 Added 414.23%	554,119 $113 Million
Q1 2019 May 14, 2019	BUY	$216.71 - $338.96 $6.7 Million - $10.5 Million	30,916 Added 40.23%	107,758 $25.5 Million
Q4 2018 Feb 14, 2019	SELL	$278.5 - $352.75 $52.8 Million - $66.9 Million	-189,643 Reduced 71.16%	76,842 $23.1 Million
Q3 2018 Nov 14, 2018	BUY	$293.51 - $383.83 $32.7 Million - $42.8 Million	111,438 Added 71.87%	266,485 $94.2 Million
Q2 2018 Aug 14, 2018	SELL	$257.52 - $306.91 $74.4 Million - $88.7 Million	-289,001 Reduced 65.08%	155,047 $45 Million
Q1 2018 May 15, 2018	BUY	$260.13 - $367.91 $101 Million - $143 Million	389,965 Added 721.05%	444,048 $122 Million
Q4 2017 Feb 14, 2018	SELL	$307.64 - $344.58 $41.1 Million - $46.1 Million	-133,645 Reduced 71.19%	54,083 $17.2 Million
Q3 2017 Nov 14, 2017	BUY	$281.15 - $329.69 $52.8 Million - $61.9 Million	187,728	187,728 $58.8 Million

Others Institutions Holding BIIB

# of Institutions

1,036

Shares Held

126M

Call Options Held

1.13M

Put Options Held

1.43M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $22.5B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account